192 related articles for article (PubMed ID: 19953630)
1. Anticancer effect of photodynamic therapy with hexenyl ester of 5-aminolevulinic acid in oral squamous cell carcinoma.
Moon YH; Park JH; Kim SA; Lee JB; Ahn SG; Yoon JH
Head Neck; 2010 Sep; 32(9):1136-42. PubMed ID: 19953630
[TBL] [Abstract][Full Text] [Related]
2. The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells.
Yoon JH; Yoon HE; Kim O; Kim SK; Ahn SG; Kang KW
Lasers Surg Med; 2012 Jan; 44(1):76-86. PubMed ID: 22246987
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with hexenyl ester of 5-aminolevulinic acid induces necrotic cell death in salivary gland adenocarcinoma cells.
Park JH; Moon YH; Kim DJ; Kim SA; Lee JB; Ahn SG; Yoon JH
Oncol Rep; 2010 Jul; 24(1):177-81. PubMed ID: 20514459
[TBL] [Abstract][Full Text] [Related]
4. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
5. Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy.
Ishida N; Watanabe D; Akita Y; Nakano A; Yamashita N; Kuhara T; Yanagishita T; Takeo T; Tamada Y; Matsumoto Y
Clin Exp Dermatol; 2009 Apr; 34(3):385-9. PubMed ID: 19077103
[TBL] [Abstract][Full Text] [Related]
6. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia.
Yanase S; Nomura J; Matsumura Y; Nagai K; Kinoshita M; Nakanishi H; Ohnishi Y; Tokuda T; Tagawa T
Int J Oncol; 2005 Jul; 27(1):193-201. PubMed ID: 15942660
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate enhances 5-aminolevulinic acid-mediated photodynamic therapy-induced killing of human SCC4 cells by upregulation of coproporphyrinogen oxidase.
Yang DF; Lee JW; Chen HM; Huang Z; Hsu YC
J Formos Med Assoc; 2014 Feb; 113(2):88-93. PubMed ID: 24485831
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
10. Addition of novel degenerate electrical waveform stimulation with photodynamic therapy significantly enhances its cytotoxic effect in keloid fibroblasts: first report of a potential combination therapy.
Sebastian A; Allan E; Allan D; Colthurst J; Bayat A
J Dermatol Sci; 2011 Dec; 64(3):174-84. PubMed ID: 22015050
[TBL] [Abstract][Full Text] [Related]
11. Differential in vitro sensitivity of oral precancerous and squamous cell carcinoma cell lines to 5-aminolevulinic acid-mediated photodynamic therapy.
Wang X; Jin J; Li W; Wang Q; Han Y; Liu H
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101554. PubMed ID: 31479802
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin upregulation by 5-aminolaevulinic acid-based photodynamic therapy in human skin squamous cell carcinoma cell line.
Kuhara T; Watanabe D; Akita Y; Takeo T; Ishida N; Nakano A; Yamashita N; Ohshima Y; Kawada M; Yanagishita T; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):142-6. PubMed ID: 18477133
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells.
Sinha AK; Anand S; Ortel BJ; Chang Y; Mai Z; Hasan T; Maytin EV
Br J Cancer; 2006 Aug; 95(4):485-95. PubMed ID: 16868543
[TBL] [Abstract][Full Text] [Related]
14. Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma.
Qin J; Zhou C; Zhu M; Shi S; Zhang L; Zhao Y; Li C; Wang Y; Wang Y
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101907. PubMed ID: 32619712
[TBL] [Abstract][Full Text] [Related]
15. Resistance of oral cancer cells to 5-ALA-mediated photodynamic therapy.
Rosin FCP; Teixeira MG; Pelissari C; Corrêa L
J Cell Biochem; 2018 Apr; 119(4):3554-3562. PubMed ID: 29227548
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol enhances 5-aminolevulinic acid-induced fluorescence and the effect of photodynamic therapy in human glioma.
Chen X; Wang C; Teng L; Liu Y; Chen X; Yang G; Wang L; Liu H; Liu Z; Zhang D; Zhang Y; Guan H; Li X; Fu C; Zhao B; Yin F; Zhao S
Acta Oncol; 2014 Mar; 53(3):405-13. PubMed ID: 24032442
[TBL] [Abstract][Full Text] [Related]
18. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy (PDT) - Initiation of apoptosis via activation of stress-activated p38 MAPK and JNK signal pathway in H460 cell lines.
Wu RW; Yow CM; Wong CK; Lam YH
Photodiagnosis Photodyn Ther; 2011 Sep; 8(3):254-63. PubMed ID: 21864799
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometry study of the role of superoxide anion and hydrogen peroxide in cellular photodestruction with 5-aminolevulinic acid-induced protoporphyrin IX.
Gilaberte Y; Pereboom D; Carapeto FJ; Alda JO
Photodermatol Photoimmunol Photomed; 1997; 13(1-2):43-9. PubMed ID: 9361128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
